|
|
|
|
LEADER |
02745nam a2200385 a 4500 |
001 |
1903313 |
005 |
20171111234738.0 |
008 |
040120s2002 enka ob 000 0 eng d |
020 |
|
|
|a 030956610X
|q (electronic bk.)
|
020 |
|
|
|a 9780309566100
|q (electronic bk.)
|z 0309084695
|q (pbk.)
|q (pbk.)
|
040 |
|
|
|a REDDC
|b eng
|e pn
|z 9780309084697
|
050 |
|
4 |
|a QR189.5.H46
|b I45 2002eb
|
245 |
0 |
0 |
|a Immunization safety review :
|b hepatitis B vaccine and demyelinating neurological disorders /
|c Kathleen Stratton, Donna A. Almario, and Marie C. McCormick, editors.
|
260 |
|
|
|a Washington, D.C. ;
|b National Academies Press,
|c ©2002.
|a [Great Britain] :
|
300 |
|
|
|a 1 online resource (xiv, 106 pages) :
|b illustrations
|
504 |
|
|
|a Includes bibliographical references (pages 85-90).
|
505 |
8 |
|
|a ""Evidence from Animal Models for a Possible Role for Hepatitis B Vaccine in Demyelination""""Evidence from Humans""; ""Known Effects of Other Vaccines""; ""Conclusions Regarding Biological Mechanisms""; ""SIGNIFICANCE ASSESSMENT""; ""Disease Burden Associated with Multiple Sclerosis""; ""Hepatitis B Vaccine Safety Concerns in France""; ""Hepatitis B Virus Infection""; ""Prevention Strategies""; ""Acceptance of the Hepatitis B Vaccine in the United States""; ""Information on the Safety of the Hepatitis B Vaccine""; ""Conclusions""; ""RECOMMENDATIONS FOR PUBLIC HEALTH RESPONSE""
|
505 |
8 |
|
|a ""Policy Review""""Research""; ""Surveillance""; ""Basic and Clinical Science""; ""Communication""; ""SUMMARY""; ""REFERENCES""; ""Appendix A Committee Conclusions and Recommendations from Previous Reports ""; ""MEASLES-MUMPS-RUBELLA VACCINE AND AUTISM""; ""Conclusions""; ""Recommendations""; ""Public Health Response""; ""Policy Review""; ""Research Regarding MMR and ASD""; ""Communications""; ""THIMEROSAL-CONTAINING VACCINES AND NEURODEVELOPMENTAL DISORDERS""; ""Conclusions""; ""Public Health Response Recommendations""; ""Policy Review and Analysis""
|
650 |
|
0 |
|a Hepatitis B
|x Vaccination.
|
650 |
|
0 |
|a Hepatitis B vaccine.
|
650 |
|
0 |
|a Demyelination
|x Vaccination.
|
650 |
|
0 |
|a Immunization
|x Complications.
|
650 |
|
0 |
|a Vaccination
|x Complications.
|
650 |
|
2 |
|a Hepatitis B Vaccines
|x adverse effects.
|
650 |
|
2 |
|a Demyelinating Diseases
|x etiology.
|
650 |
|
4 |
|a Demyelination
|x Vaccination.
|
650 |
|
4 |
|a Hepatitis B
|x Vaccination.
|
650 |
|
4 |
|a Hepatitis B vaccine.
|
650 |
|
4 |
|a Immunization
|x Complications.
|
650 |
|
4 |
|a Vaccination
|x Complications.
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|
651 |
|
2 |
|a United States.
|
700 |
1 |
|
|a Almario, Donna A.
|
856 |
4 |
0 |
|a McCormick, Marie C.
|u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=121296
|
952 |
|
|
|a CY-NiOUC
|b 5a0466346c5ad14ac1eee693
|c 998a
|d 945l
|e -
|t 1
|x m
|z Books
|